Stay updated with breaking news from Real World Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Clinical services and drug development company Emyria Ltd (ASX:EMD) has made a strategic change to its board to bolster its clinical service growth in...
Guidelines urge single-chamber ICDs for primary prevention, but dual-chamber implants are still common and may pose harm.
Contrary to the results of a seminal study in the field, a recent analysis presented today at the Society of NeuroInterventional Surgery's (SNIS) 20th Annual Meeting indicates that surgical approaches (embolization, microsurgery, radiosurgery) for treating selected patients with unruptured arteriovenous malformation (AVM) is safe and effective.
Timothy Pluard, MD, discusses recent data from an age-based subgroup analysis of RIGHT Choice, which compares the efficacy of combination ribociclib/ET versus chemotherapy in the first-line treatment of HR+/HER2- advanced breast cancer.
Experts on HR+/HER2- breast cancer review recent real-world data on CDK4/6 inhibitors and share excitement about first-line trials that have not yet read out.